Premium
Porphyrin‐Based Metal−Organic Framework Compounds as Promising Nanomedicines in Photodynamic Therapy
Author(s) -
Yu Wenmei,
Zhen Wenqiang,
Zhang Qizhi,
Li Yanchun,
Luo Hongyu,
He Jun,
Liu Yunmei
Publication year - 2020
Publication title -
chemmedchem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.817
H-Index - 100
eISSN - 1860-7187
pISSN - 1860-7179
DOI - 10.1002/cmdc.202000353
Subject(s) - porphyrin , photodynamic therapy , metal organic framework , nanotechnology , nanomedicine , drug delivery , materials science , nanomaterials , combinatorial chemistry , cancer therapy , organic molecules , quenching (fluorescence) , biocompatibility , chemistry , molecule , photochemistry , fluorescence , cancer , organic chemistry , medicine , nanoparticle , quantum mechanics , adsorption , physics
Porphyrin photosensitizers are widely used in photodynamic therapy (PDT) because of their unique diagnostic and therapeutic functions. However, many factors such as poor water solubility and instability of porphyrin compounds have limited their clinical application. Metal–organic frameworks (MOFs) have the beneficial characteristics of versatility, high porosity, and excellent biocompatibility. Porphyrin‐MOF nanomaterials have attracted the attention of researchers because MOFs can effectively suppress the quenching caused by the self‐aggregation of porphyrin compounds and promote drug delivery. This article reviews the latest applications of porphyrin‐MOF nanomedicine in type II photodynamic therapy by increasing tumour cell oxygen concentration, depleting tumour cell functional molecules and releasing signal molecules. Current potential limitations and future applications are also emphasized and discussed herein.